Stability Reigns: Sofia Real Estate Market Thrives Despite Uncertain Times
The real estate sector in Sofia has shown resilience in the face of ongoing pandemic challenges, maintaining stability across all segments in the first quarter of the year
The financial crisis forced manufacturers to seek foreign markets and take into account their price levels, says Ognyan Donev, boss of pharmaceutical company Sopharma, and alleged monopolist in Bulgaria.
Donev spoke Thursday in an interview for Nova TV, commenting on recent and numerous reports that his company sells medications in Bulgaria with prices times higher than the same ones sold in neighboring Turkey and Serbia.
The pharmaceutical boss explained that countries, which are not members of the EU, lead protectionist policies for their local products, and manufacturers must choose between being limited only to the Bulgarian market, which would lead to some local workers losing their jobs, or seek opportunities to expand abroad.
He also stressed that locally Bulgarian-made medications, which are paid for by the National Health Insurance Fund, NZOK, have "bottom" prices while over-regulation does not allow prices to go both down and up.
Donev further rejected reports that Sopharma has monopoly in selling medications to hospitals (a 7.2% share, compared to 4 other businesses with 20% share, according to him), saying it ranks 12th-15th among those companies receiving money from NZOK, while its share on the country's pharmaceutical market is about 5.2% - or a total of BGN 60 M in sales in a BGN 2 B market.
"Ten years ago, Sopharma was second after another Bulgarian company in receiving money from NZOK, but we were pushed to the side by aggressive policies of foreign businesses," said he.
Donev rejected reports he was in conflict with the recently resigned NZOK Head Neli Nesheva or that Deputy Health Minister, Gergana Pavlova, who was fired a few days ago by Prime Minister, Boyko Borisov, had ever worked for Sopharma and favored it while at the post, as it was reported.
On Monday, Bulgaria's parliamentary health commission said it is about to launch a probe into Sopharma over suspicions of monopoly.
The move came following an investigation by TV 7 channel, which showed that Sopharma sells its medicines to Bulgarian patients and hospitals at higher prices than in Turkey or Serbia.
A package of ampoules for severe allergy, for example, costs about BGN 70 in Bulgaria, while its price in Turkey is just BGN 25. A medicine for high blood pressure is sold at BGN 7 in Serbia, while in Bulgaria the price is three times higher.
The investigation also showed that the pharmaceutical boss, who recently turned into a media mogul as well, will lose about BGN half B if health authorities decide to put their house in order.
Earlier this month it emerged that the European Commission is about to launch an investigation into Sopharma over suspicions of monopoly as unethical as in an African country.
Sopharma, controlled by Ognyan Donev, who until a year ago was a member of the supervisory board of NZOK, has managed to supply more than 70% of the medicines required by (state) hospitals and more than 50% of prescribed medicines, according to media reports.
The other key person in the scheme is believed to be the fired Bulgarian Deputy Health Minister, Gergana Pavlova, said to have been a former high-ranking employee of Sopharma.
According to a New Europe publication the European Commission is already in Bulgaria, investigating the case 'sur place'.
Ognyan Donev and Lyubomir Pavlov became partners and media moguls in April last year after acquiring WAZ Mediengruppe assets amid accusations of an attempted corporate mini-coup.
The transaction included Trud and 24 Hours daily newspapers, 168 Hours weekly newspaper, Trud weekly, a few magazines, eight regional newspapers, a printing house, the distribution company Strela (Arrow) and ZGB's headquarters in downtown Sofia and across the country.
Donev and Pavlov are at war with the other large media group in Bulgaria, and TV7 is part of their enemies.
We need your support so Novinite.com can keep delivering news and information about Bulgaria! Thank you!
As of 2022, the count of fellow countrymen who purchased real estate overseas reached 2,154, based on data from the National Revenue Agency referenced by "Telegraph"
Bulgaria's long-anticipated entry into the Eurozone may face a delay, as the country is unlikely to meet the inflation criterion required for the introduction of the euro on January 1, 2025
FlixBus, the renowned European bus company, is set to launch new routes to and from Bulgaria in anticipation of the summer season
In a significant development, the Russian army has seized control of the pivotal village of Ocheretyne in the Donetsk region of Ukraine, a strategic location crucial for Ukrainian defense efforts
The price of retail lamb in Bulgaria has surged by 8.4% on an annual basis, according to statistics released by the Ministry of Agriculture and Food, with data sourced from SAPI indicating an average price of BGN 25.27 per kilogram as of April 10
In a concerning revelation, the ad hoc committee investigating the activities of Gleb Myshin uncovered that over the past three to four years, a staggering 343 candidates from the Russian Federation seeking Bulgarian citizenship were discovered to have su
UN Happiness Report: Bulgaria's Astonishing Leap in Rankings
Bulgaria: 3 Regions With Lowest Life Expectancy - EU Report 2022